Search

everythinglearnresearchcommunity

for

Search:↓

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

The document reports three sisters with Woodhouse-Sakati syndrome showing typical symptoms and unusual gynecological anomalies.

Glioblastoma cells can make androgens, which might help the tumor grow.

Injecting cosyntropin into grizzly bears increases blood cortisol but doesn't change hair cortisol levels.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

Phthirusa pyrifolia extract may lower testosterone and harm male rat reproduction without damaging the liver or kidneys.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

A teenager lost hair due to fluoxetine and sertraline, but it grew back after stopping these drugs and switching to a different one.

Finasteride use may be linked to rare testicular tumor, but more research needed.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Chronic stress in mice changes skin metabolism and gene expression, leading to hair loss.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Researchers identified genes in scalp hair follicles that may affect hair traits and hair loss.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Most female students at Qassim University know about PCOS, but there are still misunderstandings about it.